drugset
drugset / Trial / NCT06356194

Drug-drug Interaction Study of Biktarvy and Bemnifosbuvir/Ruzasvir

NCT06356194 ↗

Phase 1 Completed 28 enrolled Atea Pharmaceuticals, Inc.
Non-randomizedCrossoverOpen-labelTreatment

Summary

Drug-drug interaction study of Biktarvy and Bemnifosbuvir/Ruzasvir

Timeline

Start
2024-04-15
Primary completion
2024-05-30
Completion
2024-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Bemnifosbuvir Other / unclassified — —
Subject Biktarvy Other / unclassified — —
Subject Ruzasvir Other / unclassified — —

Indications

No indication recorded.